1. Di, Yuqin, Jing, Xiaoqian, Hu, Kunhua, Wang, Ziyang, He, Weiling. 2022. The c-MYC-WDR43 signalling axis promotes chemoresistance and tumour growth in colorectal cancer by inhibiting p53 activity. In Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 66, 100909. doi:10.1016/j.drup.2022.100909. https://pubmed.ncbi.nlm.nih.gov/36525936/
2. Qin, Yuhan, Yan, Gaoliang, Qiao, Yong, Wang, Dong, Tang, Chengchun. 2023. Identification of hub genes based on integrated analysis of single-cell and microarray transcriptome in patients with pulmonary arterial hypertension. In BMC genomics, 24, 788. doi:10.1186/s12864-023-09892-3. https://pubmed.ncbi.nlm.nih.gov/38110868/
3. Bi, Xianju, Xu, Yanhui, Li, Tong, Li, Pilong, Shen, Xiaohua. 2019. RNA Targets Ribogenesis Factor WDR43 to Chromatin for Transcription and Pluripotency Control. In Molecular cell, 75, 102-116.e9. doi:10.1016/j.molcel.2019.05.007. https://pubmed.ncbi.nlm.nih.gov/31128943/
4. Sun, Haijun, Sun, Qi, Qiu, Xie, Li, Aimin, Dai, Jianhua. 2022. WD repeat domain 43 promotes malignant progression of non-small cell lung cancer by regulating CDK2. In The international journal of biochemistry & cell biology, 151, 106293. doi:10.1016/j.biocel.2022.106293. https://pubmed.ncbi.nlm.nih.gov/36041702/
5. Heng, Hongquan, Liu, Jie, Hu, Mingwei, Su, Wenxing, Li, Jian. 2022. WDR43 is a potential diagnostic biomarker and therapeutic target for osteoarthritis complicated with Parkinson's disease. In Frontiers in cellular neuroscience, 16, 1013745. doi:10.3389/fncel.2022.1013745. https://pubmed.ncbi.nlm.nih.gov/36419937/
6. Mendoza-Fandiño, Gustavo, Lyra, Paulo Cilas M, Nepomuceno, Thales C, Couch, Fergus J, Monteiro, Alvaro N A. 2021. Two distinct mechanisms underlie estrogen-receptor-negative breast cancer susceptibility at the 2p23.2 locus. In European journal of human genetics : EJHG, 30, 465-473. doi:10.1038/s41431-021-01005-6. https://pubmed.ncbi.nlm.nih.gov/34803163/
7. Wang, Xingqiao, Kong, Fanqiang, Lin, Zengbin. 2023. Cromolyn prevents cerebral vasospasm and dementia by targeting WDR43. In Frontiers in aging neuroscience, 15, 1132733. doi:10.3389/fnagi.2023.1132733. https://pubmed.ncbi.nlm.nih.gov/37122373/